Home/ marches MARCHESBiophytis receives approval for OBA clinical study in BrazilBiophytis receives approval for its OBA clinical study in Brazil.Published 2h·1 source Lire en françaisListen≈ 13sSpeed0.8×1×1.2×1.5×The factThe BIO101 treatment targets neuromuscular diseases.First results are expected in Q1 2027.🔗Click the link to read an article on the topic:Boursorama↗🧭Explore this topicBrésilBiophytis#Biophytis#BIO101#Brésil#étude clinique#maladies neuromusculaires#pharmacieWhat if you saw the whole news differently?Factae cross-checks hundreds of sources worldwide to keep only the fact, no opinion. Explore the front page.→BrésilWorld map →Follow topic →↗ Share the newsAuto-synthesis from 1 media source · identified on August 10, 2026← Back to home